Processa Pharmaceuticals Inc. (NASDAQ: PCSA) reported Q3 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Processa Pharmaceuticals Inc. (PCSA) click here.